Capital Markets Update with EQL Pharma - March 7th

2025-03-07 09:00:00 CET

EQL Pharma AB (publ), a leading Niche Pharmaceuticals Company, is pleased to invite investors and other interested parties to a capital markets update on Friday, March 7, 2025.

EQL Pharma’s CEO Axel Schörling will present an updated investor presentation and will be accompanied by Alexander Brising (Chief Commercial Officer) and Carl Lindgren (Chief Business Development Officer).

During the presentation, EQL will share its new financial targets and strategic plan with a special focus on how the company plans to reach its new targets.

The event will be held at Carnegie’s premises in Stockholm, Sweden and a live webcast will be available for those who cannot attend in person.

Location: Regeringsgatan 56, 111 56 Stockholm Date & Time: 7 March 2025, 09:00-12:00 CET

For inquiries regarding one-on-one meetings or other event-related questions, kindly send an email to ellen.mioen@carnegie.se